vs
Side-by-side financial comparison of MEDIFAST INC (MED) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $75.1M, roughly 1.0× MEDIFAST INC). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -36.9%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-6.6M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
MED vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $76.2M |
| Net Profit | — | $5.6M |
| Gross Margin | 69.4% | 57.9% |
| Operating Margin | -10.4% | 11.0% |
| Net Margin | — | 7.4% |
| Revenue YoY | -36.9% | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $-1.64 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $76.2M | ||
| Q3 25 | $89.4M | $71.9M | ||
| Q2 25 | $105.6M | $63.1M | ||
| Q1 25 | $115.7M | $59.1M | ||
| Q4 24 | $119.0M | $60.7M | ||
| Q3 24 | $140.2M | $58.0M | ||
| Q2 24 | $168.6M | $55.0M | ||
| Q1 24 | $174.7M | $50.6M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | $-2.3M | $3.5M | ||
| Q2 25 | $2.5M | $3.2M | ||
| Q1 25 | $-772.0K | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $1.1M | $3.9M | ||
| Q2 24 | $-8.2M | $1.5M | ||
| Q1 24 | $8.3M | $1.6M |
| Q4 25 | 69.4% | 57.9% | ||
| Q3 25 | 69.5% | 57.5% | ||
| Q2 25 | 72.6% | 58.3% | ||
| Q1 25 | 72.8% | 56.3% | ||
| Q4 24 | 74.1% | 59.5% | ||
| Q3 24 | 75.4% | 59.3% | ||
| Q2 24 | 73.2% | 59.8% | ||
| Q1 24 | 72.8% | 58.9% |
| Q4 25 | -10.4% | 11.0% | ||
| Q3 25 | -4.6% | 7.8% | ||
| Q2 25 | -1.0% | 8.1% | ||
| Q1 25 | -1.1% | 6.5% | ||
| Q4 24 | 0.6% | 10.6% | ||
| Q3 24 | 1.5% | 9.7% | ||
| Q2 24 | -4.7% | 6.6% | ||
| Q1 24 | 4.5% | 4.4% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | -2.5% | 4.9% | ||
| Q2 25 | 2.3% | 5.0% | ||
| Q1 25 | -0.7% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | 0.8% | 6.7% | ||
| Q2 24 | -4.8% | 2.7% | ||
| Q1 24 | 4.8% | 3.2% |
| Q4 25 | $-1.64 | $0.14 | ||
| Q3 25 | $-0.21 | $0.09 | ||
| Q2 25 | $0.22 | $0.08 | ||
| Q1 25 | $-0.07 | $0.06 | ||
| Q4 24 | $0.08 | $0.10 | ||
| Q3 24 | $0.10 | $0.10 | ||
| Q2 24 | $-0.75 | $0.04 | ||
| Q1 24 | $0.76 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $141.5M |
| Total Assets | $248.0M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $13.5M | ||
| Q3 25 | $173.5M | $11.1M | ||
| Q2 25 | $162.7M | $20.0M | ||
| Q1 25 | $164.6M | $10.2M | ||
| Q4 24 | $162.3M | $17.5M | ||
| Q3 24 | $170.0M | $11.3M | ||
| Q2 24 | $163.5M | $8.8M | ||
| Q1 24 | $156.4M | $7.3M |
| Q4 25 | $198.9M | $141.5M | ||
| Q3 25 | $214.7M | $133.6M | ||
| Q2 25 | $216.0M | $139.7M | ||
| Q1 25 | $211.0M | $134.8M | ||
| Q4 24 | $210.1M | $131.4M | ||
| Q3 24 | $207.3M | $125.0M | ||
| Q2 24 | $205.3M | $119.4M | ||
| Q1 24 | $211.0M | $116.3M |
| Q4 25 | $248.0M | $199.2M | ||
| Q3 25 | $268.2M | $202.4M | ||
| Q2 25 | $269.3M | $184.6M | ||
| Q1 25 | $280.0M | $178.1M | ||
| Q4 24 | $284.2M | $177.1M | ||
| Q3 24 | $291.2M | $169.5M | ||
| Q2 24 | $293.5M | $163.9M | ||
| Q1 24 | $302.8M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $18.4M |
| Free Cash FlowOCF − Capex | $-6.6M | $9.7M |
| FCF MarginFCF / Revenue | -8.8% | 12.7% |
| Capex IntensityCapex / Revenue | 1.8% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $18.4M | ||
| Q3 25 | $12.1M | $18.4M | ||
| Q2 25 | $-3.4M | $12.3M | ||
| Q1 25 | $3.4M | $2.9M | ||
| Q4 24 | $-4.9M | $15.0M | ||
| Q3 24 | $9.1M | $12.7M | ||
| Q2 24 | $13.1M | $10.2M | ||
| Q1 24 | $7.3M | $1.2M |
| Q4 25 | $-6.6M | $9.7M | ||
| Q3 25 | $10.8M | $10.7M | ||
| Q2 25 | $-4.8M | $4.1M | ||
| Q1 25 | $1.9M | $-12.6M | ||
| Q4 24 | $-7.2M | $3.2M | ||
| Q3 24 | $7.7M | $1.7M | ||
| Q2 24 | $11.1M | $1.2M | ||
| Q1 24 | $5.4M | $-4.8M |
| Q4 25 | -8.8% | 12.7% | ||
| Q3 25 | 12.0% | 14.9% | ||
| Q2 25 | -4.5% | 6.5% | ||
| Q1 25 | 1.6% | -21.4% | ||
| Q4 24 | -6.1% | 5.2% | ||
| Q3 24 | 5.5% | 3.0% | ||
| Q2 24 | 6.6% | 2.3% | ||
| Q1 24 | 3.1% | -9.5% |
| Q4 25 | 1.8% | 11.5% | ||
| Q3 25 | 1.5% | 10.6% | ||
| Q2 25 | 1.3% | 12.9% | ||
| Q1 25 | 1.3% | 26.2% | ||
| Q4 24 | 1.9% | 19.5% | ||
| Q3 24 | 1.0% | 19.0% | ||
| Q2 24 | 1.1% | 16.3% | ||
| Q1 24 | 1.1% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | -1.36× | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 8.04× | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | 0.88× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
